Dr Reddys Laboratories (RDY) Long-Term Deferred Tax: 2018-2025
Historic Long-Term Deferred Tax for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $217.0 million.
- Dr Reddys Laboratories' Long-Term Deferred Tax rose 68.22% to $217.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $217.0 million, marking a year-over-year increase of 68.22%. This contributed to the annual value of $217.0 million for FY2025, which is 68.22% up from last year.
- Dr Reddys Laboratories' Long-Term Deferred Tax amounted to $217.0 million in FY2025, which was up 68.22% from $129.0 million recorded in FY2024.
- In the past 5 years, Dr Reddys Laboratories' Long-Term Deferred Tax ranged from a high of $217.0 million in FY2025 and a low of $88.0 million during FY2023.
- Moreover, its 3-year median value for Long-Term Deferred Tax was $129.0 million (2024), whereas its average is $144.7 million.
- As far as peak fluctuations go, Dr Reddys Laboratories' Long-Term Deferred Tax fell by 25.52% in 2022, and later soared by 68.22% in 2025.
- Dr Reddys Laboratories' Long-Term Deferred Tax (Yearly) stood at $145.0 million in 2021, then fell by 25.52% to $108.0 million in 2022, then declined by 18.52% to $88.0 million in 2023, then soared by 46.59% to $129.0 million in 2024, then soared by 68.22% to $217.0 million in 2025.